Heartware International, (FRA:HIY1) Change In Receivables : €-3.0 Mil (TTM As of Jun. 2016)

View and export this data going back to . Start your Free Trial

What is Heartware International, Change In Receivables?

Heartware International,'s change in receivables for the quarter that ended in Jun. 2016 was €-8.7 Mil. It means Heartware International,'s Accounts Receivable increased by €8.7 Mil from Mar. 2016 to Jun. 2016 .

Heartware International,'s change in receivables for the fiscal year that ended in Dec. 2015 was €0.8 Mil. It means Heartware International,'s Accounts Receivable declined by €0.8 Mil from Dec. 2014 to Dec. 2015 .

Heartware International,'s Accounts Receivable for the quarter that ended in Jun. 2016 was €34.4 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Heartware International,'s Days Sales Outstanding for the three months ended in Jun. 2016 was 51.38.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Heartware International,'s liquidation value for the three months ended in Jun. 2016 was €-23.9 Mil.

Heartware International, Change In Receivables Historical Data

The historical data trend for Heartware International,'s Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heartware International, Change In Receivables Chart

Heartware International, Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Change In Receivables

Get a 7-Day Free Trial

2.76

-7.92

-1.73

-9.56

0.82

Heartware International, Quarterly Data
	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16
Change In Receivables	Get a 7-Day Free Trial															1.16	0.64	-0.94	5.99	-8.74

Heartware International, Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.0 Mil.

Heartware International, (FRA:HIY1) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Heartware International,'s Days Sales Outstanding for the quarter that ended in Jun. 2016 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	34.441	/	61.161	*	91
=	51.38

2. In Ben Graham's calculation of liquidation value, Heartware International,'s accounts receivable are only considered to be worth 75% of book value:

Heartware International,'s liquidation value for the quarter that ended in Jun. 2016 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	164.848	-	231.471	+	0.75 * 34.441	+	0.5 * 33.699
=	-23.9

Heartware International, Change In Receivables Related Terms

Thank you for viewing the detailed overview of Heartware International,'s Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Heartware International, (FRA:HIY1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heartware International, Inc. (FRA:HIY1) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.heartware.com

Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.

Heartware International, (FRA:HIY1) Headlines

No Headlines